Latest Conference

Michael D. Nailor, PharmD, BCPS-AQ ID, clinical associate professor at the University of Connecticut School of Pharmacy, clinical specialist in infectious diseases at Hartford Hospital, and director of Infectious Disease Residency program at Hartford Hospital, discusses the prevalence of skin and soft tissue infections in the United States.

At the annual meeting of Infectious Diseases Society of America, researchers revealed that in addition to microcephaly, other neurological consequences of Zika virus are being recognized.

Holly Frost, MD, pediatrics physician scientist at the Marshfield Clinic Research Foundation, in Minocqua, Wisconsin, explains what Powassan virus is.

Susan Kline, MD, MPH, associate professor of medicine, Division of Infectious Diseases and International Medicine, medical director for Infection Control, lead physician for Antibiotic Stewardship, at the University of Minnesota, discusses the growing problem of antibiotic-resistance in hospital-acquired infections.

A trio of speakers addressed the global problem of antibiotic resistance and how the problem is especially vexing in Africa, Asia, and Latin America, at the annual conference of the Infectious Diseases Society of America in New Orleans, Louisiana.

Daniel Eiras, MD, MPH, hospital epidemiologist at NYU Langone Medical Center, discusses the prevalence of Zika virus infections in New York City.

During ID Week, Robert Read, MD, from University Hospital Southampton in Southampton, UK, discussed how a better understanding of meningococcal disease has led to more effective treatment strategies.

At the annual meeting of the Infectious Diseases Society of America in New Orleans, Louisiana, Judith Currier, MD, from the University of California, Los Angeles, discussed the many challenges that HIV-positive individuals face as they live longer lives.

Madeline King, PharmD, assistant professor of Clinical Pharmacy at the University of the Sciences, Philadelphia College of Pharmacy in Philadelphia, Pennsylvania, discusses ceftazidime-avibactam and its uses.

Rebekah Stewart Schicker, MSN, MPH, APRN, Epidemic Intelligence Service (EIS) Officer at the Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Influenza Division, discusses which outpatient populations are at highest risk of influenza-associated complications and the recommended treatments for these individuals.

Rita Olans, DNP, CPNP-PC, APRN-BC, assistant professor at MGH Institute of Health Professions, discusses the importance of incorporating staff nurses in a healthcare setting's antimicrobial stewardship program.

Vikas Gupta, PharmD, BCPS, director of Clinical Strategy at Becton Dickinson, discusses his research on the national prevalence of multidrug-resistant organisms.

Speakers at the Infectious Diseases Society of America annual conference plenary symposium in New Orleans, Louisiana, discuss past successes, current challenges, and future efforts regarding infectious disease.

Zika has been around for a long time, with the first report dating back to 1947. Until 2007, only 14 cases had been reported. Subsequently, there have been three outbreaks, culminating with its arrival in the Americas in the 2015 epidemic in Brazil.

At the Infectious Diseases Society of America Meeting, in New Orleans, Louisiana, Octavio Ramilo, MD, Nationwide Children’s Hospital, Columbus, Ohio, gave a lecture on advancements being made when it comes to host response and pathogenesis of respiratory syncytial virus.

Kenneth Fife, MD, PhD, Professor of Medicine at Indiana University, School of Medicine, discusses whether or not his genital herpes vaccine, GEN-003, can protect against oral herpes.

Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, discusses the prognosis of babies with Zika-related complications.

Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, discusses whether or not all Zika-infected pregnant women will infect their fetuses.

Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, discusses the likelihood that fetuses congenitally infected with the Zika virus will develop related complications, such as microcephaly.

Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, discusses the possibility of the Zika virus evolving to cause other complications in the future.

Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, explains how Zika has evolved since the 1960s.

Andrew Chasteen from Accelerate Diagnostics, Inc, explains future applications of Morphokinetic Cellular Analysis (MCA).

Kirk Hevener, PharmD, PhD, assistant professor of Biomedical and Pharmaceutical Sciences at Idaho State University, College of Pharmacy, explains his research regarding topoisomerase I and II enzymes.

Kirk Hevener, PharmD, PhD, assistant professor of Biomedical and Pharmaceutical Sciences at Idaho State University, College of Pharmacy, discusses the advantages of narrow spectrum antibiotics.

Kirk Hevener, PharmD, PhD, assistant professor of Biomedical and Pharmaceutical Sciences at Idaho State University, College of Pharmacy, explains how clinicians can identify pathogenic organisms to determine which narrow spectrum antibiotic to use for treatment.

Justin R. Anderson, PhD, associate professor of biology at Radford University, explains the factors that make some people more susceptible to contracting mosquito-borne viruses.

Justin R. Anderson, PhD, associate professor of biology at Radford University, discusses what factors will aid mosquito control specialists in eradicating vector populations.

Justin R. Anderson, PhD, associate professor of biology at Radford University, discusses how endocrine disrupting chemicals interact with larvae to change infected mosquitoes.